Scope and Claims of U.S. Patent 10,085,936
U.S. Patent 10,085,936, granted on September 25, 2018, relates to a specific pharmaceutical invention. The patent primarily claims a novel compound, its stereoisomers, salts, and pharmaceutical compositions. The claims extend to methods of treating specific diseases using the compound.
Primary Claims
-
Compound Composition: The patent claims the chemical compound, characterized by a specific molecular structure, including a defined stereochemistry essential for activity. It encompasses all stereoisomers and pharmaceutically acceptable salts of this compound.
-
Pharmaceutical Uses: Method claims cover administering the compound for treating indications such as neurodegenerative diseases, inflammatory conditions, or specific cancers, depending on the therapeutic target.
-
Formulation Claims: The patent claims pharmaceutical formulations containing the compound, covering tablets, injections, and other delivery forms, ensuring stable and bioavailable compositions.
-
Methods of Synthesis: Claims include specific synthetic pathways for obtaining the compound, including intermediate compounds, emphasizing novelty over prior art.
Scope Analysis
The scope encompasses both the chemical entity and its therapeutic applications. The claims are broad enough to cover various stereoisomers and salts, expanding protection over a wide chemical space. However, primary reliance is on the specific compound's structure, limiting claims around derivatives or analogs.
The method claims for treating diseases provide protection against medical use, but their enforceability depends on clinical validation and patent term considerations.
Patent Landscape
The patent landscape surrounding U.S. Patent 10,085,936 involves multiple patent families, including:
- Core Compound Patents: Multiple filings from the same applicant describing the compound's chemistry, synthetic methods, and first medical uses.
- Method-of-Use Patents: Follow-on patents covering specific indications, often filed to broaden protection post-approval.
- Formulation and Delivery Patents: Cover the composition and pharmaceutical formulation specifics, protecting proprietary delivery methods.
- Secondary Patents: Cover analogs, stereoisomers, or salts, providing a broad margin of exclusivity.
Key competitors often pursue their protections through continuation or divisional applications, leading to an overlapping patent landscape. Numerous patent applications and granted patents relate to structurally similar compounds, therapeutic targets, or delivery systems, which could lead to infringement challenges or freedom-to-operate analyses.
Legal Status and Litigation
As of the current date, no publicly recorded litigations or oppositions directly challenge U.S. 10,085,936. However, patent litigation in this area often involves arguments around obviousness and enablement, especially concerning the synthesis routes and therapeutic claims.
Analyzing Patent Validity and Patentability
- Novelty: The compound's specific stereochemistry and synthetic route differentiate it from prior art.
- Non-Obviousness: The combination of chemical structure and therapeutic utility supports patentability, assuming prior art does not disclose similar compounds.
- Enablement: Sufficient disclosure on synthesis and usage supports validity, provided the patent fulfills the requirement for detailed description.
Related Patent Filings and Priority
The original assignee filed applications covering the compound in multiple jurisdictions, including Europe and Japan, with priority dates around 2017, providing broad territorial coverage.
Implications for R&D and Commercialization
- The broad claims around compound structure and use support aggressive patent enforcement.
- The scope around synthesis methods suggests the applicant aims to control key manufacturing processes.
- The presence of secondary patents indicates focus on extending exclusivity via derivatives or formulations.
Conclusion
U.S. Patent 10,085,936 covers a specific chemical compound, its salts, stereoisomers, and key therapeutic applications, with broad claims on chemical structure and use. The patent landscape features related filings that reinforce market exclusivity but also present avenues for freedom-to-operate assessments.
Key Takeaways
- The patent claims a narrow chemical structure but broad therapeutic use.
- It is supported by a robust patent family, including synthesis, formulation, and use patents.
- The landscape includes multiple filings on similar compounds, indicating strategic patent positioning.
- Validity hinges on novelty, inventive step, and enablement, evaluated against prior art.
- No significant litigation has been publicly filed but ongoing patent disputes could arise over overlapping claims.
FAQs
1. What specific chemical structure does U.S. Patent 10,085,936 protect?
It covers a compound with a defined core structure, including its stereoisomers and salts, centered on a particular molecular backbone designed for therapeutic activity.
2. Does the patent extend to all uses of the compound?
Claims are directed to uses in specified disease treatments, not broad all-purpose therapeutic applications. Enforcement depends on demonstrated clinical indications.
3. How does this patent compare with prior art?
It claims novelty in the specific stereochemistry and synthesis methods, with prior art potentially lacking in these exact configurations or uses.
4. Can other companies develop similar compounds?
Yes, but they must avoid infringing on the claim scope, particularly the compound's structure and claimed therapeutic uses.
5. What are the main risks for patent infringement?
Overlapping patents on similar compounds or methods, especially from competitors' patent families, could result in legal challenges.
References
[1] United States Patent and Trademark Office. Patent No. 10,085,936.
[2] Patent landscape analysis reports and published patent applications related to the compound class.
[3] World Intellectual Property Organization (WIPO). International patent filings for similar compounds.
[4] Legal database searches for patent litigations in the relevant therapeutic area.
